SSDP Organizes to Influence FDA Psychedelic Drug Comments

The Students for a Sensible Drug Policy (SSDP) activist group wants to influence comments to the U.S. Food and Drug Administration (FDA) on psychedelic drugs. The FDA is accepting public comments through October 5th after holding a recent hearing on the issue. So SSDP is encouraging researchers, clinicians, patients, advocates, people with experience, and members … Continue reading SSDP Organizes to Influence FDA Psychedelic Drug Comments